Evidence map›Paper›PMID 29593444›Full record

ArticleJournal of equine science2018

Blood glucose is unlikely to be a prognostic biomarker in acute colitis with systemic inflammatory response syndrome in Thoroughbred racehorses.

Shuntaro Urayama, Daisuke Arima, Fumiaki Mizobe, Yuta Shinzaki, Motoi Nomura, Yohei Minamijima, Kanichi Kusano

Open access · diamondAbstract read
In one paragraph

Article in Journal of equine science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Activated platelets and platelet-leukocyte aggregates in the equine systemic inflammatory response syndrome.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shuntaro UrayamaRacehorse Hospital, Miho Training Center, Japan Racing Association, Ibaraki 300-0493, Japan.
Daisuke ArimaRacehorse Hospital, Miho Training Center, Japan Racing Association, Ibaraki 300-0493, Japan.
Fumiaki MizobeRacehorse Hospital, Ritto Training Center, Japan Racing Association, Shiga 520-3085, Japan.
Yuta ShinzakiRacehorse Hospital, Ritto Training Center, Japan Racing Association, Shiga 520-3085, Japan.
Motoi NomuraRacehorse Hospital, Ritto Training Center, Japan Racing Association, Shiga 520-3085, Japan.
Yohei MinamijimaLaboratory of Racing Chemistry, Tochigi 320-0851, Japan.
Kanichi KusanoRacehorse Hospital, Miho Training Center, Japan Racing Association, Ibaraki 300-0493, Japan.
Japan Racing Association · JPLaboratory of Racing Chemistry · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although hyperglycemia at admission with colic has been reported to have a poor prognosis, there is no report specifically about acute colitis with systemic inflammatory response syndrome (SIRS) in horses. In this study, we measured blood glucose (Glu), insulin (Ins), and cortisol (Cor) levels in 17 Thoroughbred racehorses diagnosed as having acute colitis with SIRS, and examined the relationship between time-dependent changes in Glu, Ins, and Cor and prognosis. Glu levels were high in 3 horses at admission, but thereafter no horses had persistently high Glu levels. There was no significant difference in Glu, Ins, and Cor levels within 72 hr between surviving and non-surviving horses. In conclusion, the Glu level is unlikely to be a useful prognostic biomarker in acute colitis with SIRS.

Indexed as

colitisglucoseSIRSThoroughbred

Identifiers

PMID29593444
PMCPMC5865065
OpenAlexW2795802713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.